Compounds > clarithromycin
Page last updated: 2024-08-25

clarithromycin and Experimental Neoplasms

clarithromycin has been researched along with Experimental Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hara, N; Hayashi, S; Turuta, N; Wakamatsu, K; Yatsunami, J1
Hara, N; Nakanishi, Y; Takano, K; Takayama, K; Tsuruta, N; Wakamatsu, K; Yanami, J1
Akashi, T; Sone, S; Yamagishi, T; Yano, S1

Other Studies

3 other study(ies) available for clarithromycin and Experimental Neoplasms

ArticleYear
Clarithromycin is a potent inhibitor of tumor-induced angiogenesis.
    Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie, 1997, Volume: 197, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Carcinoma, Squamous Cell; Clarithromycin; Humans; Lung Neoplasms; Mice; Neoplasms, Experimental; Neovascularization, Pathologic

1997
[Tumor neovascularization inhibiting and tumor proliferation and metastasis suppressing actions of 14-, 15-, and 16-member ring macrolides].
    The Japanese journal of antibiotics, 1998, Volume: 51 Suppl A

    Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Immunologic Factors; Josamycin; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Neovascularization, Pathologic; Roxithromycin

1998
[Significance of therapeutic efficacy of clarithromycin in a model for human lung cancer metastasis and a mouse tumor system].
    The Japanese journal of antibiotics, 1998, Volume: 51 Suppl A

    Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Immunologic Factors; Lung Neoplasms; Mice; Mice, SCID; Neoplasms, Experimental

1998